You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 5, April 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Oral Progesterone Therapy

Oxygen in a Pill

Allan L. Goldman, MD; Douglass Morrison, MD; Larry J. Foster, MD

Arch Intern Med. 1981;141(5):574.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Chronic hypoxia can lead to complications including pulmonary hypertension, cor pulmonale, polycythemia, or impaired neuropsychological function. Chronic hypoxia caused by intrinsic lung disease can result from ventilation perfusion mismatching, shunting, or diffusion abnormalities. In some patients, hypoxia can be improved by treating the underlying lung disease, whereas in others, supplemental oxygen therapy may be required. Oxygen is expensive and inconvenient to use, but it is beneficial for the previously mentioned complications, particularly in nonsmokers.

Hypoxia can also result from alveolar hypoventilation, which is indicated by an elevated Paco2. Hypoventilation is caused by conditions that impair the mechanical function of the lungs, eg, severe chronic obstructive pulmonary disease (COPD), or by primary disorders of respiratory control, eg, the obesity-hypoventilation (Pickwickian) syndrome. It is useful to think of patients with severe intrinsic lung disease as the "can't breathe" group and the patients with primary respiratory control center defects as the "won't . . . [Full Text PDF of this Article]


Author Affiliations

University of South Florida College of Medicine 12901 N 30th St Tampa, FL 33612



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.